iXpressGenes is a research organization focused on the early detection and prevention of trauma-induced illnesses, particularly post-traumatic stress disorder (PTSD). The company has identified a set of biomarkers that can signal the onset of PTSD and other related conditions by analyzing specific profiles within the immune system. Their innovative approach includes the Trauma Autoimmune Indicator (TAI) Screening, which measures immune responses to detect trauma-related health issues. This method aims to provide individualized prevention strategies for trauma-related diseases, highlighting the importance of early intervention in improving patient outcomes.

The organization has conducted preliminary studies analyzing T cell receptor transcriptome sequences, which link immune responses to sensitivity or resilience to PTSD. Their research indicates a distinct immune profile among individuals exposed to trauma, differentiating those with PTSD symptoms from those without. By mapping RNA transcriptomes to proteins integral to the immune system, iXpressGenes is pioneering a novel approach to understanding and addressing trauma-induced illnesses, thereby contributing to the advancement of personalized medicine in this critical area of health.

United States

iXpressGenes is a synthetic biology company thatspecializes in protein services and instrumentation, and protein and genetic engineering research. The company has experience withextremozymes, microgravity, and trace fluorescent labeling andaccess to a suite of hyperthermophilic genomes from the deep sea vents of the Atlantic Ridge. Proteins and enzymes from these genomes have special qualities that are useful in engineering and metabolic reactions.

iXpressGenes

Company Details